Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.62 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.50 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.47 |
| ▸ | PRKCG | P05129 | 1/20 | 0.47 |
| ▸ | PRKCB | P05771 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKCH | P24723 | 1/20 | 0.47 |
| ▸ | PRKCI | P41743 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.47 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2131879 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL2308275 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL20506755 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL20506768 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL21086628 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL20506761 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL20506759 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL22129693 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL20506756 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA | |
| SCHEMBL20835139 | 1.00 | ACE2 (0.62) | ACE2OPRM1TSHRTHRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702842-A1 | COMPOSITION, ANT CONTROL AGENT, AND CONTROL METHOD FOR ANTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-04 | — | — | EP | claimed |
| WO-2024225248-A1 | COMPOSITION, ANT CONTROL AGENT, AND CONTROL METHOD FOR ANTS | 信越化学工業株式会社 | 2024-10-31 | — | — | WO | claimed |
| EP-4458792-B1 | 1-HALO-2,6,14-TRIMETHYLOCTADECANE COMPOUND AND PROCESS FOR PREPARING 5,13,17-TRIMETHYLALKANE COMPOUND THEREFROM | SHINETSU CHEMICAL CO (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-4702842-A1 | COMPOSITION, ANT CONTROL AGENT, AND CONTROL METHOD FOR ANTS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4464685-B1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | SHINETSU CHEMICAL CO (JP) | 2026-02-04 | — | — | EP | disclosed |
| EP-4464685-A1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-11-20 | — | — | EP | disclosed |
| US-20240368061-A1 | 1-HALO-2,6,14-TRIMETHYLOCTADECANE COMPOUND AND PROCESS FOR PREPARING 5,13,17-TRIMETHYLALKANE COMPOUND THEREFROM | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-11-07 | — | — | US | disclosed |
| US-20240368056-A1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-11-07 | — | — | US | disclosed |
| EP-4458792-A1 | 1-HALO-2,6,14-TRIMETHYLOCTADECANE COMPOUND AND PROCESS FOR PREPARING 5,13,17-TRIMETHYLALKANE COMPOUND THEREFROM | Shin-Etsu Chemical Co., Ltd. (JP) | 2024-11-06 | — | — | EP | disclosed |
| WO-2024225248-A1 | COMPOSITION, ANT CONTROL AGENT, AND CONTROL METHOD FOR ANTS | 信越化学工業株式会社 | 2024-10-31 | — | — | WO | disclosed |
| US-11571372-B2 | Branched saturated hydrocarbon cosmetic ingredient | BIOSYNTHIS (FR) | 2023-02-07 | — | — | US | disclosed |
| US-20200383888-A1 | BRANCHED SATURATED HYDROCARBON COSMETIC INGREDIENT | BIOSYNTHIS (FR) | 2020-12-10 | — | — | US | disclosed |
| US-20180243187-A1 | BRANCHED SATURATED HYDROCARBON COSMETIC INGREDIENT | BIOSYNTHIS (FR) | 2018-08-30 | — | — | US | disclosed |
| US-9701893-B2 | Process for producing mineral oil using surfactants based on a mixture of C32 guerbet-, C34 guerbet-, C36 guerbet-containing alkyl alkoxylates | BASF SE (DE) | 2017-07-11 | — | — | US | disclosed |
| US-20150353818-A1 | PROCESS FOR PRODUCING MINERAL OIL USING SURFACTANTS BASED ON A MIXTURE OF C32 GUERBET-, C34 GUERBET-, C36 GUERBET-CONTAINING ALKYL ALKOXYLATES | BASF SE (DE) | 2015-12-10 | — | — | US | disclosed |
| US-6755902-B2 | YELLOW DYE; THERMAL STABILITY; LIGHTFASTNESS; SOLUBILITY; SHARP DURABLE IMAGES; NONCLOGGING | XEROX CORPORATION | 2004-06-29 | — | — | US | disclosed |
| US-20040007155-A1 | Phase change inks containing azo pyridone colorants | XEROX CORPORATION | 2004-01-15 | — | — | US | disclosed |
| US-6590082-B1 | Color materials used as inks in phase change recording and dyeing of textiles, high spectral emmitance chromogens, electronics, optical and color filters | XEROX CORPORATION | 2003-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11571372-B2 | Branched saturated hydrocarbon cosmetic ingredient | H1-0, SQLE, HRH1 | ACE2 4223/4885OPRM1 438/4885TSHR 2256/4885 |
| US-20240368061-A1 | 1-HALO-2,6,14-TRIMETHYLOCTADECANE COMPOUND AND PROCESS FOR PREPARING 5,13,17-TRIMETHYLALKANE COMPOUND THEREFROM | MSMO1, CYP4Z1, B2M | ACE2 2205/4885OPRM1 249/4885TSHR 2734/4885 |
| US-20240368056-A1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | CYP4Z1, CYP51A1, MSMO1 | ACE2 2789/4885OPRM1 2081/4885TSHR 4372/4885 |
| US-20200383888-A1 | BRANCHED SATURATED HYDROCARBON COSMETIC INGREDIENT | H1-0, SQLE, HRH1 | ACE2 4223/4885OPRM1 438/4885TSHR 2256/4885 |
| US-20180243187-A1 | BRANCHED SATURATED HYDROCARBON COSMETIC INGREDIENT | H1-0, SQLE, DEGS1 | ACE2 4119/4885OPRM1 533/4885TSHR 2639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.